CIPRAFAMIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C21H24N2O
Molecular Weight	320.4281
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O=C(CN1CCCC1)NC2[C@@H]([C@H]2C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=OZAREULYFHAGNW-WOJBJXKFSA-N

InChI=1S/C21H24N2O/c24-18(15-23-13-7-8-14-23)22-21-19(16-9-3-1-4-10-16)20(21)17-11-5-2-6-12-17/h1-6,9-12,19-21H,7-8,13-15H2,(H,22,24)/t19-,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C21H24N2O
Molecular Weight	320.4281
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=19760504&DB=EPODOC&locale=en_EP&CC=US&NR=3954778A&KC=A&ND=4

Ciprafamide is an aminoacetyl derivative invented by Zambon S.p.A. in 1971. The drug is claimed to possess anticonvulsant and anti-cardiac arrhythmias activity.

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:24:42 GMT 2025` Edited by `admin` on `Mon Mar 31 18:24:42 GMT 2025`
Record UNII	PU98C417NB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

N-(CIS-2,TRANS-3-DIPHENYLCYCLOPROPYL)-1-PYRROLIDINEACETAMIDE

Preferred Name

English

CIPRAFAMIDE

Official Name

English

ciprafamide [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C47793